Factors specific for lectin pathway of complement activation in patients with haematological malignancies, receiving autologous haematopoietic stem cell transplantations

2013/11/B/NZ6/01739

Keywords

Descriptors

  • NZ6_1: Odporność swoista i nieswoista
  • NZ6_2: Immunologia kliniczna

Panel

NZ6 – Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology

Host institution

Instytut Biologii Medycznej PAN

Voivodeship: łódzkie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr hab. Maciej Cedzyński

Number of co-investigators in the project: 14

Call

OPUS 6 – announced on 2013-09-16

Amount awarded
846 840 PLN
Project start date
2014-11-04
Project end date
2018-11-03
Project duration
48 months (the same as in the proposal)
Project status
Project settled

Equipment purchased [PL]

  1. komora laminarna klasy 2. Cost: 58 000 PLN
  2. pH-metr z wyposażeniem.

Information in the final report

Publication in academic press/journals (5)

  1. Associations of ficolins and mannose-binding lectin with acute myeloid leukaemia in adults

    Authors:
    Sokołowska A, Świerzko AS, Gajek G, Gołos A, Michalski M, Nowicki M, Szala-Poździej A, Wolska-Washer A, Brzezińska O, Wierzbowska A, Jamroziak K, Kowalski ML, Thiel S, Matsushita M, Jensenius JC, Cedzyński M.
    Academic press:
    Scientific Reports (year: 2020, volume: 10, pages: 10561), Publisher: Nature Research
    Status:
    Published
    DOI:
    10.1038/s41598-020-67516-2 – link to the publication
  2. Components of the lectin pathway of complement in haematologic malignancies.

    Authors:
    Cedzyński M., Śwsierzko A.S.
    Academic press:
    Cancers (year: 2020, volume: 12, pages: 1792), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/cancers12071792 – link to the publication
  3. Associations of ficolins with haematological malignancies in patients receiving high-dose chemotherapy and autologous haematopoietic stem cell transplantations (auto-HSCT).

    Authors:
    Świerzko AS, Michalski M, Sokołowska A, Nowicki M, Szala-Poździej A, Eppa Ł, Mitrus I, Szmigielska-Kapłon A, Sobczyk-Kruszelnicka M, Michalak K, Gołos A, Wierzbowska A, Giebel S, Jamroziak K, Kowalski ML, Brzezińska O, Thiel S, Matsushita M, Jensenius JC, Gajek G, Cedzyński M.
    Academic press:
    Frontiers in Immunology (year: 2020, volume: 2020 Jan 28; 10, pages: 3097), Publisher: Frontiers Media SA
    Status:
    Published
    DOI:
    10.3389/fimmu.2019.03097 – link to the publication
  4. Znaczenie czynników aktywacji dopełniacza na drodze lektynowej w chorobach nowotworowych

    Authors:
    Cedzyński M., Świerzko A.S.
    Academic press:
    Journal of Health Study and Medicine (year: 2017, volume: 5, pages: 13332), Publisher: SAN
    Status:
    Published
  5. The Role of Complement Activating Collectins and Associated Serine Proteases in Patients With Hematological Malignancies, Receiving High-Dose Chemotherapy, and Autologous Hematopoietic Stem Cell Transplantations (Auto-HSCT).

    Authors:
    Świerzko AS, Michalski M, Sokołowska A, Nowicki M, Eppa Ł, Szala-Poździej A, Mitrus I, Szmigielska-Kapłon A, Sobczyk-Kruszelnicka M, Michalak K, Gołos A, Wierzbowska A, Giebel S, Jamroziak K, Kowalski ML, Brzezińska O, Thiel S, Jensenius JC, Kasperkiewicz K, Cedzyński M
    Academic press:
    Frontiers in Immunology (year: 2018, volume: 2018 Sep 20;9, pages: 2153), Publisher: Frontiers Media SA
    Status:
    Published
    DOI:
    10.3389/fimmu.2018.02153 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski